Merck’s Newly Approved Capvaxive Could Have Edge Over Prevnar 20 In Adults

 
• By Jessica Merrill
  
pneumococcal vaccine
Merck & Co.'s 21-valent pneumococcal vaccine was approved by FDA • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip